Skip to main content
SpringerLink
Log in

Omburtamab I-131

Pseudoprogression of central nervous system neuroblastoma: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Kramer K, et al. Central nervous system neuroblastoma metastases pseudoprogression following intraventricular anti-B7H3 radioimmunotherapy. Neuro-Oncology 21 (Suppl. 2): ii95, Apr 2019. Available from: URL: http://doi.org/10.1093/neuonc/noz036.131 [abstract] - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Omburtamab I-131. Reactions Weekly 1769, 335 (2019). https://doi.org/10.1007/s40278-019-67349-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-67349-y

Search

Navigation